Endocrine implications of obesity and bariatric surgery

被引:15
|
作者
Dyaczynski, Michal [1 ]
Scanes, Colin Guy [2 ]
Koziec, Helena [3 ]
Pierzchala-Koziec, Krystyna [4 ]
机构
[1] Siemianowice Slaskie Municipal Hosp, Dept Gen Surg, Siemianowice Slaskie, Poland
[2] Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA
[3] Josef Babinski Clin Hosp, Krakow, Poland
[4] Agr Univ Krakow, Dept Anim Physiol & Endocrinol, Al Mickiewicza 24-28, PL-30059 Krakow, Poland
关键词
obesity; endocrine dysfunctions; bariatric surgery; gastrointestinal hormones; Y GASTRIC BYPASS; TYPE-2; DIABETES-MELLITUS; PLASMA GHRELIN LEVELS; INDUCED WEIGHT-LOSS; PEPTIDE-YY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FOOD-INTAKE; GASTROINTESTINAL HORMONES; ENERGY-EXPENDITURE;
D O I
10.5603/EP.2018.0059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a highly prevalent disease in the world associated with the disorders of endocrine system. Recently, it may be concluded that the only effective treatment of obesity remains bariatric surgery. The aim of the review was to compare the concepts of appetite hormonal regulation, reasons of obesity development and bariatric procedures published over the last decade. The reviewed publications had been chosen on the base on: 1. reasons and endocrine consequences of obesity; 2. development of surgery methods from the first bariatric to present and future less aggressive procedures; 3. impact of surgery on the endocrine status of patient. The most serious endocrine disturbances during obesity are dysfunctions of hypothalamic circuits responsible for appetite regulation, insulin resistance, changes in hormones activity and abnormal activity of adipocytes hormones. The currently recommended bariatric surgeries are Roux-en-Y gastric bypass, sleeve gastrectomy and adjustable gastric banding. Bariatric surgical procedures, particularly combination of restrictive and malabsorptive, decrease the body weight and eliminate several but not all components of metabolic syndrome. Conclusions: 1. Hunger and satiety are mediated by an interplay of nervous and endocrine signals. 2. Healthy adipose tissue secretion of adipokines is coordinated in an anti-inflammatory, insulin-sensitizing and cardioprotective pattern. However, with increasing fat mass this secretion pattern is changed into a proinflammatory, insulin resistant, atherogenic and fatal systemic environment. 3. Bariatric surgery is not a solution of the obesity problem for everyone. 4. Long term postsurgical observations of the hormonal profile changes are necessary and should be obligatory.
引用
收藏
页码:574 / 586
页数:13
相关论文
共 50 条
  • [21] Bariatric Surgery for Treatment of Obesity
    Weiner, R. A.
    Wechsler, J. G.
    AKTUELLE ERNAHRUNGSMEDIZIN, 2010, 35 (05): : 217 - 219
  • [22] Bariatric Surgery for Obesity and Diabetes
    Azizi, Fereidoun
    ARCHIVES OF IRANIAN MEDICINE, 2013, 16 (03) : 182 - 186
  • [23] Bariatric surgery for treatment of obesity
    Eldar, S.
    Heneghan, H. M.
    Brethauer, S. A.
    Schauer, P. R.
    INTERNATIONAL JOURNAL OF OBESITY, 2011, 35 : S16 - S21
  • [24] Is bariatric surgery a solution for obesity?
    Mary Hogan
    BMC Proceedings, 6 (Suppl 3)
  • [25] BARIATRIC SURGERY IN MONOGENIC OBESITY
    Borg, C.
    Manning, S.
    Hashemi, M.
    Batterham, R. L.
    Finer, N.
    OBESITY SURGERY, 2014, 24 (08) : 1330 - 1330
  • [26] Endocrine Function after Bariatric Surgery
    Kimand, Ki-Suk
    Sandoval, Darleen A.
    COMPREHENSIVE PHYSIOLOGY, 2017, 7 (03) : 783 - 798
  • [27] Bariatric Surgery for Morbid Obesity
    Mark J Monteforte
    Charles M Turkelson
    Obesity Surgery, 2000, 10 : 391 - 401
  • [28] Obesity, Hypertension, and Bariatric Surgery
    Rohan Samson
    Karnika Ayinapudi
    Thierry H. Le Jemtel
    Suzanne Oparil
    Current Hypertension Reports, 2020, 22
  • [29] Obesity in candidates for bariatric surgery
    Charbel Costa, Anna Christina
    Ivo, Maria Lucia
    Cantero, Wilson de Barros
    Filgueiras Tognini, Joao Ricardo
    ACTA PAULISTA DE ENFERMAGEM, 2009, 22 (01) : 55 - 59
  • [30] Bariatric surgery for morbid obesity
    Monteforte, MJ
    Turkelson, CM
    OBESITY SURGERY, 2000, 10 (05) : 391 - 401